These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30606176)

  • 1. Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research.
    Eun K; Park MG; Jeong YW; Jeong YI; Hyun SH; Hwang WS; Kim SH; Kim H
    BMC Biotechnol; 2019 Jan; 19(1):1. PubMed ID: 30606176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-mediated genome editing in sea urchins.
    Lin CY; Oulhen N; Wessel G; Su YH
    Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combinational use of CRISPR/Cas9-based gene editing and targeted toxin technology enables efficient biallelic knockout of the α-1,3-galactosyltransferase gene in porcine embryonic fibroblasts.
    Sato M; Miyoshi K; Nagao Y; Nishi Y; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S
    Xenotransplantation; 2014; 21(3):291-300. PubMed ID: 24919525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pKAMA-ITACHI Vectors for Highly Efficient CRISPR/Cas9-Mediated Gene Knockout in Arabidopsis thaliana.
    Tsutsui H; Higashiyama T
    Plant Cell Physiol; 2017 Jan; 58(1):46-56. PubMed ID: 27856772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combinational Use of CRISPR/Cas9 and Targeted Toxin Technology Enables Efficient Isolation of Bi-Allelic Knockout Non-Human Mammalian Clones.
    Watanabe S; Sakurai T; Nakamura S; Miyoshi K; Sato M
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No off-target mutations in functional genome regions of a CRISPR/Cas9-generated monkey model of muscular dystrophy.
    Wang S; Ren S; Bai R; Xiao P; Zhou Q; Zhou Y; Zhou Z; Niu Y; Ji W; Chen Y
    J Biol Chem; 2018 Jul; 293(30):11654-11658. PubMed ID: 29941452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue.
    Jin J; Xu Y; Huo L; Ma L; Scott AW; Pizzi MP; Li Y; Wang Y; Yao X; Song S; Ajani JA
    PLoS One; 2020; 15(2):e0228910. PubMed ID: 32053639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells.
    Grav LM; la Cour Karottki KJ; Lee JS; Kildegaard HF
    Methods Mol Biol; 2017; 1603():101-118. PubMed ID: 28493126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LeishGEdit: A Method for Rapid Gene Knockout and Tagging Using CRISPR-Cas9.
    Beneke T; Gluenz E
    Methods Mol Biol; 2019; 1971():189-210. PubMed ID: 30980304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells.
    Kamali E; Rahbarizadeh F; Hojati Z; Frödin M
    BMC Biotechnol; 2021 Jan; 21(1):9. PubMed ID: 33514392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of knockout adult sea urchins by using a CRISPR-Cas9 system.
    Liu D; Awazu A; Sakuma T; Yamamoto T; Sakamoto N
    Dev Growth Differ; 2019 Aug; 61(6):378-388. PubMed ID: 31359433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of genome-edited dogs by somatic cell nuclear transfer.
    Kim DE; Lee JH; Ji KB; Park KS; Kil TY; Koo O; Kim MK
    BMC Biotechnol; 2022 Jul; 22(1):19. PubMed ID: 35831828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Directed Gene Editing for the Generation of Loss-of-Function Mutants in High-Throughput Zebrafish F
    Shankaran SS; Dahlem TJ; Bisgrove BW; Yost HJ; Tristani-Firouzi M
    Curr Protoc Mol Biol; 2017 Jul; 119():31.9.1-31.9.22. PubMed ID: 28678442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application and optimization of CRISPR-Cas9-mediated genome engineering in axolotl (Ambystoma mexicanum).
    Fei JF; Lou WP; Knapp D; Murawala P; Gerber T; Taniguchi Y; Nowoshilow S; Khattak S; Tanaka EM
    Nat Protoc; 2018 Dec; 13(12):2908-2943. PubMed ID: 30429597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
    Nakagawa Y; Sakuma T; Sakamoto T; Ohmuraya M; Nakagata N; Yamamoto T
    BMC Biotechnol; 2015 May; 15():33. PubMed ID: 25997509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
    Li W; Ou G
    Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.